腸胃病藥 的英文怎麼說

中文拼音 [chángwèibìngyào]
腸胃病藥 英文
gastrointestinal agent
  • 腸 : 名詞1. （消化器官的一部分, 通稱腸子） intestines 2. （用腸衣塞肉、魚等製成的食品） sausage 3. （感情; 情緒; 情感） heart
  • 胃 : 名詞1. （消化器官的一部分） stomach 2. （二十八宿之一） wei, one of the lunar mansions
  • 病 : Ⅰ名詞1 （疾病; 失去健康的狀態） illness; sickness; disease; malum; nosema; malady; morbus; vitium...
  • 藥 : Ⅰ名詞1 （藥物） medicine; drug; remedy 2 （某些有化學作用的物質） certain chemicals Ⅱ動詞1 [書面...
  • 腸胃病 : intestinal tract disease
  • 腸胃 : intestines and stomach; belly
  1. Modern medical uses include : bronchitis, diarrhea, dysentery, hyperthyroidism, stretch marks, thrush, ulcers, vaginal thrush, viral hepatitis, asthma, athlete ' s foot, candida, catarrh ( mucus ), coughs, eczema, digestion, dyspepsia ( impaired digestion ), flatulence ( gas ), fungal infections, gingivitis, gum infections, hemorrhoids, support immune system, mouth ulcers, decongest prostate gland, ringworms, sore throats, skin conditions ( chapped and cracked ), skin inflammation, wounds, and wrinkles, toothpastes, mouthwashes, cosmetics, and food flavorings

    現代的醫藥用途包括：支氣管炎，腹瀉，痢疾，甲狀腺機能亢進，緊張，鵝口瘡，潰瘍，陰道的鵝口瘡，哮喘，腳癬，粘膜炎，咳嗽，濕疹，消化不良，腸胃氣脹，真菌感染，齒齦炎，齒齦感染，痔瘡，支持免疫系統，口潰瘍，解除前列腺充血，癬茵病，咽喉痛，皮膚問題（乾燥和裂開） ，皮膚發炎，傷口和皺紋，還可用作牙膏，漱口水，化妝品和食物調味料。
  2. Purpose : to explore the risk factors for nosocomial infection of urological surgical department. method : 2 976 cases of urological surgical patients was investigated retrospectively for the nosocomial infective prevalence in urological surgical department from the april 1996 to april 1999. result : nosocomial ratio in urological surgical department was 4. 87 %, in which 73. 1 % for male and 26. 9 % for female. the infective sites are lower respiratory tract, surgical wound, urinary tract, gastrointestinal tract, upper respiratory tract and skin - soft tissues in turn, infection rates were 4. 38 %, 10. 4 %, 13. 6 %, 27. 6 %, 25. 5 %, 30. 3 %, 20. 8 %, 42. 6 % for clean wound, dirty wound, infection wound, artery catheter, venouse catheter, urinary tract catheter, respiratory tract, and general anesthesia respectively. conclusion : the nosocomial infection was not related to age, infection time and the usage of antibiotics ; but was closely related to gender, surgical sites, surgical wound type, invasive operation, the degree of tisk index and micropathogens

    目的:探討泌尿外科醫院感染的危險因素.方法:回顧性調查1996年4月1999年4月間我院泌尿外科手術患者2976例的醫院感染情況.結果:泌尿外科醫院感染率為4 . 87 % ，其中男性佔73 . 1 % ，女性佔26 . 9 % ;感染部位依次為下呼吸道、手術傷口、泌尿道、胃腸道、上呼吸道、皮膚軟組織;類切口術后感染率為4 . 4 % ，類切口術后感染率為10 . 4 % ，類切口術后感染率為13 . 6 % ;動脈插管感染率為27 . 6 % ，靜脈插管感染率為25 . 5 % ，泌尿道插管感染率為30 . 3 % ，呼吸道感染率為20 . 8 % ，全麻感染率為42 . 6 % .結論:醫院感染與患者年齡、感染時間和抗菌藥物使用情況無關，與性別、部位分佈、手術切口類型、侵入性操作、危險指數等級及病原微生物有密切關系
  3. Abstract : purpose : to explore the risk factors for nosocomial infection of urological surgical department. method : 2 976 cases of urological surgical patients was investigated retrospectively for the nosocomial infective prevalence in urological surgical department from the april 1996 to april 1999. result : nosocomial ratio in urological surgical department was 4. 87 %, in which 73. 1 % for male and 26. 9 % for female. the infective sites are lower respiratory tract, surgical wound, urinary tract, gastrointestinal tract, upper respiratory tract and skin - soft tissues in turn, infection rates were 4. 38 %, 10. 4 %, 13. 6 %, 27. 6 %, 25. 5 %, 30. 3 %, 20. 8 %, 42. 6 % for clean wound, dirty wound, infection wound, artery catheter, venouse catheter, urinary tract catheter, respiratory tract, and general anesthesia respectively. conclusion : the nosocomial infection was not related to age, infection time and the usage of antibiotics ; but was closely related to gender, surgical sites, surgical wound type, invasive operation, the degree of tisk index and micropathogens

    文摘:目的:探討泌尿外科醫院感染的危險因素.方法:回顧性調查1996年4月1999年4月間我院泌尿外科手術患者2976例的醫院感染情況.結果:泌尿外科醫院感染率為4 . 87 % ，其中男性佔73 . 1 % ，女性佔26 . 9 % ;感染部位依次為下呼吸道、手術傷口、泌尿道、胃腸道、上呼吸道、皮膚軟組織;類切口術后感染率為4 . 4 % ，類切口術后感染率為10 . 4 % ，類切口術后感染率為13 . 6 % ;動脈插管感染率為27 . 6 % ，靜脈插管感染率為25 . 5 % ，泌尿道插管感染率為30 . 3 % ，呼吸道感染率為20 . 8 % ，全麻感染率為42 . 6 % .結論:醫院感染與患者年齡、感染時間和抗菌藥物使用情況無關，與性別、部位分佈、手術切口類型、侵入性操作、危險指數等級及病原微生物有密切關系
  4. The traditional chinese medicine think that there are many factors of disease cause, external contraction of the six excesses, dietary irregularities, affect - mind dissatisfaction, and constitutional insufficiency can cause ulcerative colitis by harming the function of spleen - stomach, discussing the relationship of the disease factors and disfunction of spleen - stomach, and probing into the diseasa cause of traditional chinese medicine to ulcerative colitis can know thoroughly the law of ulcerative colitis, that would raise the clinical curative effect of traditional chinese medicine to ulcerative colitis

    摘要中醫學研究認為多種致病因素，外感六淫、飲食不節、情志失調、稟賦不足等均可通過損傷脾胃功能而引發潰瘍性結腸炎，通過探討各致病因素與脾胃功能失調間的關系，剖析潰瘍性結腸炎的中醫病因，有助於深入了解潰瘍性結腸炎的發病機理和發病規律，提高中醫藥治療潰瘍性結腸炎的臨床療效。
  5. Prior to january 20, 2005, as glivec was not part of the standard treatment for gist, financial assistance from the samaritan fund was not available to gist patients for meeting the cost of the drug

    （二）二五年一月二十日之前，由於胃腸道基質腫瘤的標準治療方法並不包括加以域，因此撒瑪利亞基金並沒有資助胃腸道基質腫瘤病人購買這種藥物。
  6. It has been reported that " glivec " for the treatment of gastrointestinal stromal tumour and chronic myeloid leukaemia has been classified by the hospital authority ( ha ) as first - line drug, and patients who have to take the drug and have financial difficulties will be referred to apply for drug subsidy from the samaritan fund

    據報，醫院管理局（醫管局）將治療胃腸基質瘤及慢性骨髓性白血病的藥物加以域定為第一線藥物，並會安排須服用該藥物而有經濟困難的病人申請撒瑪利亞基金的藥費資助。
  7. Based on these properties of no, new drugs can be developed for the treatment of hypertension, stroke, angina pectoris, heart failure, vascular complications of diabetes, gastrointestinal ulcers, impotency and other vascular disorders

    科研人員可利用一氧化氮這些特性，開發出新藥以治療高血壓中風心絞痛心臟衰竭糖尿病引起的血管並發癥腸胃潰瘍陽萎，及其他心血管失調。
  8. In traditional chinese medicine the bile salts of bear gallbladders are considered powerful medicine for the treatment of various intestinal and cardiac - related illnesses

    在傳統中醫，熊膽的膽汁鹽被認為是治療各類胃腸與心臟相關疾病的強效藥。
  9. At present, the traditional chinese medicine which is developed and has a special therapeutic effectiveness includes the cosmetic and healthy food which can resist aging and lots of prescription which can cure gout, hepatic disease, gastrointestinal disease, trachitis, chronic cholecystitis, arthritis, rheumatoid arthritis ( ra ), scapulohumeral periarthritis, gynecopathy, oral ulcer, rhinitis, inflammatory swelling of unknown origin, venereal disease ( vd ), angitis, diabetes, hypertension and so on

    目前開發的具有獨特療效的中藥有：道家秘傳抗衰老保健美容益壽食品，治療痛風病、各種肝病、各種腸胃道病、氣管炎、慢性膽囊炎、關節炎、類風濕關節炎、肩周炎、各種婦科病、口腔潰瘍、各種鼻炎、無名腫毒、各種性病、脈管炎、糖尿病、慢性咽炎、高血壓病等多種方劑。
  10. Slimming drugs commonly used appetite inhibitors, these drugs through the hypothalamus to influence diet and the central body of the excitement and inhibition play appetite, patients readily accept diet therapy, such as amphetamine - type ; metandienone increase metabolism, is to promote metabolism, so the body ' s adipose tissue accumulation by gradually eliminate, such as thyroid hormone ; biguanides hypoglycemic agents, the drugs in the treatment of diabetes, patients can cause loss of appetite, this is the side effects, but the drug has reduced the cumulative amount of fat and suppress appetite, delaying or reducing gastrointestinal absorption of the sugar, increase fecal fat and he substances excreted, speaking on obesity and is beneficial side

    常用減肥藥物有食慾抑制劑，這類藥物是通過對下丘腦飲食中樞發生影響以及對全身的興奮而起到食慾抑制作用，使病人易於接受飲食療法，如苯丙胺類；增加代謝類藥，是促進機體代謝，使體內蓄積的脂肪組織逐漸消除，如甲狀腺激素；雙胍類降血糖藥，本類藥物在治療糖尿病時，可引起病人食欲不振，本是副作用，但此藥有降低脂肪積存量的作用，抑制食慾，延緩或減少胃腸道對糖分的吸收，增加糞便中脂肪及其他物質的排泄，對肥胖者來說恰是有利的一面。
  11. Bighead atractylodes rhizome and poria cocos have the effects of reinforce the spleen to replenish qi, enriching the blood and production of sperm and are also the adjuvant drugs. in this prescription, there are also fructus cannabis and bunge cherry seed that can loose the bowel to relieve constipation. so gizzard - membrane smoothness tablet has the effects of strengthening the spleen and stomach, regulating the flow of qi to alleviate pain and loosing the bowel to relieve constipation

    組成配方：以內金為主藥，藥理如上述尚有焦山楂，焦麥芽，對胃消化不良，惡心，反胃有奇效，故為君藥丁香一味，則有胃痛剋星之美譽，是為臣藥山藥，茯苓等健脾益氣，養血生精而佐藥尚有火麻仁，郁李仁等潤腸通便為使，故內金暢通片具有健脾和胃，理氣止痛，潤腸通便之效果尤其內金化積肉消腫塊，更切合前列腺腫大之病情，其效甚著。
  12. Efalizumab was generally well tolerated. significant side effects included thrombocytopenia, viral gastroenteritis and worsening eczema despite drug discontinuation

    依法利珠單抗可以很好的被耐受。明顯的副作用包括血小板減少，病毒性胃腸炎和停藥后仍然出現的濕疹的惡化。
  13. Analysis endoscopic expression of 60 cases of gastrointestinal ulcer and acute mucosal disease by nonsteroidal anti - inflammatory drugs

    非甾體類藥物致消化道潰瘍病及急性胃腸粘膜病變60例內鏡特徵分析
  14. In active stage, external treatment can also be used to accelerate the effect of chinese medicine on lesion and protect stomach - qi ; since pathogen usually intrudes into collaterals in protracted disease, insect drugs is needed to pick out wind - damp pathogen and to invigorate kidney and dredge collaterals

    治療上，活動期可加用外治法，有利於藥物更快作用於病變關節並保護腸胃；久病入絡可加蟲類藥以搜剔風濕之邪，補腎通絡。
  15. This allows for an extensive opportunity to develop novel drugs to treat common disorders such as hypertension, stroke, atherosclerosis, angina pectoris, heart failure, and gastrointestinal ulcers

    醫學界可利用一氧化氮研製更多新藥，治療高血壓中風動脈硬化心絞痛心臟衰竭腸胃潰瘍等多種常見疾病。
  16. This allows for an extensive opportunity to develop novel drugs for the diagnosis, prevention and treatment of a multitude of cardiovascular and other disorders such as gastrointestinal ulcers and inflammatory bowel disease

    這意味著醫學界仍有大量空間去研製新藥，用以診斷預防與治療多種心血管疾病腸胃潰瘍，和炎性腸道疾病等失調癥。
  17. October 17, 2007 ( philadelphia ) ? mesalamine use in patients with inflammatory bowel disease ( ibd ) is associated with a significant risk reduction in colorectal cancer, a single - center study presented here at the american college of gastroenterology 2007 annual scientific meeting and postgraduate course has found

    2007年10月17日費城報道-在2007年美國大學胃腸病學科學年會上，一個研究小組指出，用於腸炎患者的藥物馬沙拉嗪可以顯著降低用藥患者罹患大腸癌的風險，后續的研究工作正在展開。
  18. The gi research team of the department of medicine and therapeutics at the chinese university of hong kong led by professor francis chan ka - leung performed the first double - blind randomized trial to compare plavix with the combination of aspirin and a proton - pump inhibitor for patients who had previous ulcer bleeding

    由香港中文大學內科及藥物治療學系教授陳家亮教授率領的腸胃科研究小組，完成了首個雙盲隨機測試的研究，比較曾患潰瘍病人服用plavix及服用亞士匹靈加上胃酸抑制劑兩者的療效。
分享友人
分享到 Line

分享到臉書